BIOMEDICA Medizinprodukte GmbH & Co KG Sustainability Profile
BIOMEDICA Medizinprodukte GmbH & Co KG, headquartered in Austria, is a prominent player in the medical technology industry, specialising in the development and distribution of innovative medical products. Founded in 1992, the company has established a strong presence across Europe, particularly in the DACH region, and is recognised for its commitment to quality and excellence. The core offerings of BIOMEDICA include advanced wound care solutions, surgical instruments, and diagnostic devices, all designed to enhance patient outcomes. What sets BIOMEDICA apart is its focus on integrating cutting-edge technology with user-friendly designs, ensuring that healthcare professionals can deliver optimal care. With a reputation for reliability and innovation, BIOMEDICA continues to solidify its market position, contributing significantly to the advancement of medical practices.
DitchCarbon Score
How does BIOMEDICA Medizinprodukte GmbH & Co KG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
BIOMEDICA Medizinprodukte GmbH & Co KG's score of 31 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
BIOMEDICA Medizinprodukte GmbH & Co KG, headquartered in Austria (AT), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of AddLife AB (publ), which may influence its climate commitments and reporting practices. While there are no documented reduction targets or specific climate pledges from BIOMEDICA, it is important to note that emissions data and performance metrics may be cascaded from its parent company, AddLife AB (publ). This relationship suggests that BIOMEDICA may align its sustainability efforts with the broader initiatives and targets set by AddLife AB. As a part of the medical products industry, BIOMEDICA is likely to be influenced by increasing regulatory and market pressures to enhance sustainability practices. The absence of specific emissions data highlights an opportunity for the company to establish clear climate commitments and reduction targets in the future, aligning with industry standards and expectations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 3,966,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 514,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | 00,000,000 | 000,000,000 |
How Carbon Intensive is BIOMEDICA Medizinprodukte GmbH & Co KG's Industry?
How Carbon Intensive is BIOMEDICA Medizinprodukte GmbH & Co KG's Location?
BIOMEDICA Medizinprodukte GmbH & Co KG's Scope 3 Categories Breakdown
BIOMEDICA Medizinprodukte GmbH & Co KG's Scope 3 emissions, which increased significantly last year and increased significantly since 2023, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 84% of Scope 3 emissions.
Top Scope 3 Categories
BIOMEDICA Medizinprodukte GmbH & Co KG's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
BIOMEDICA Medizinprodukte GmbH & Co KG has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
